Inspire Medical Systems (INSP) shares plunged 5.86% in pre-market trading on Tuesday, February 11, 2025, after multiple analysts lowered their price targets on the stock.
Truist Securities cut its price target on INSP to $235 from $250, though it maintained a Buy rating on the medical device company. Meanwhile, Wells Fargo also reduced its price target on INSP to $195 from $198.
The downward revisions in analysts' price targets appear to be the primary reason behind INSP's pre-market sell-off, as investors reacted negatively to the lowered expectations for the stock's future performance.